PRMT5 and lymphoma: The overlap of the highly depleted genes in the T0 control between the two independent screens, confirmed that PRMT5 is one of the few genes identified in our CRISPR screens as essential for lymphoma and clinically actionable (Supplementary Fig. 1I).